# ATTR-CM: A Multi-country, Non-interventional Disease Registry

> **NCT06651073** · — · ACTIVE_NOT_RECRUITING · sponsor: **Pfizer** · enrollment: 350 (actual)

## Conditions studied

- Transthyretin Amyloid Cardiopathy

## Interventions

- **OTHER:** Observational

## Key facts

- **NCT ID:** NCT06651073
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2028-04-28
- **Final completion:** 2028-04-28
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06651073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06651073, "ATTR-CM: A Multi-country, Non-interventional Disease Registry". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT06651073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*